Who
Sean Werner
Chief Technology Officer
Company insider
Files Form 4 as: Chief Technology Officer, BioLife Solutions.
In numbers
- Trades disclosed
- 26
- Buys
- 0
- Sells
- 10
- Bought
- $0
- Sold
- $53K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 3 Mar 2025
- Last trade
- 6 Oct 2026
- Last filed
- 8 Oct 2026
Companies traded
Activity over time
1 Mar 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 6 Oct 2026filed 8 Oct 2026 | BioLife SolutionsMedical Devices | SEC FORM 4 Code A | —45,838 | filing |
| 6 Oct 2026filed 8 Oct 2026 | BioLife SolutionsMedical Devices | SEC FORM 4 Code A | —48,232 | filing |
| 6 Oct 2026filed 8 Oct 2026 | BioLife SolutionsMedical Devices | SEC FORM 4 Code F | $2.8M71,226 at $38.61 | filing |
| 6 Oct 2026filed 8 Oct 2026 | BioLife SolutionsMedical Devices | SEC FORM 4 Code D | —69,979 | filing |
| 18 Sep 2026filed 22 Sep 2026 | BioLife SolutionsMedical Devices | SEC FORM 4 Code F | $15K421 at $36.69 | filing |
| 18 Sep 2026filed 22 Sep 2026 | BioLife SolutionsMedical Devices | SEC FORM 4 Code F | $15K421 at $36.69 | filing |
| 17 Jul 2026filed 21 Jul 2026 | BioLife SolutionsMedical Devices | SEC FORM 4 Code F | $8,016275 at $29.15 | filing |
| 17 Jul 2026filed 21 Jul 2026 | BioLife SolutionsMedical Devices | SEC FORM 4 Code F | $8,016275 at $29.15 | filing |
| 18 Jun 2026filed 22 Jun 2026 | BioLife SolutionsMedical Devices | SEC FORM 4 Code F | $11K420 at $26.04 | filing |
| 18 Jun 2026filed 22 Jun 2026 | BioLife SolutionsMedical Devices | SEC FORM 4 Code F | $11K420 at $26.04 | filing |
| 19 Mar 2026filed 23 Mar 2026 | BioLife SolutionsMedical Devices | SEC FORM 4 Code F | $32K1,681 at $19.12 | filing |
| 19 Mar 2026filed 23 Mar 2026 | BioLife SolutionsMedical Devices | SEC FORM 4 Code F | $32K1,681 at $19.12 | filing |
| 3 Mar 2026filed 5 Mar 2026 | BioLife SolutionsMedical Devices | SEC FORM 4 Sold | $2,302111 at $20.74 | filing |
| 3 Mar 2026filed 5 Mar 2026 | BioLife SolutionsMedical Devices | SEC FORM 4 Sold | $2,302111 at $20.74 | filing |
| 24 Feb 2026filed 26 Feb 2026 | BioLife SolutionsMedical Devices | SEC FORM 4 Code A | —24,116 | filing |
| 24 Feb 2026filed 26 Feb 2026 | BioLife SolutionsMedical Devices | SEC FORM 4 Code A | —24,116 | filing |
| 25 Nov 2025filed 28 Nov 2025 | BioLife SolutionsMedical Devices | SEC FORM 4 Sold | $2,941110 at $26.74 | filing |
| 20 Oct 2025filed 22 Oct 2025 | BioLife SolutionsMedical Devices | SEC FORM 4 Sold | $7,651275 at $27.82 | filing |
| 11 Sep 2025filed 15 Sep 2025 | BioLife SolutionsMedical Devices | SEC FORM 4 Sold | $1,93272 at $26.83 | filing |
| 26 Aug 2025filed 28 Aug 2025 | BioLife SolutionsMedical Devices | SEC FORM 4 Sold | $2,824111 at $25.44 | filing |
News
No headline names them, or the companies they trade most, lately.